Thursday 4th March 2021
EY will be hosting a webcast on Thursday, 4 March at 3pm (UK time) for an analysis of the UK Budget. Our tax specialists and EY ITEM Club will discuss the economic impact of the Chancellor’s announcements on 3 March and assess the key tax implications for individuals, employers and businesses.
Whether or not we see tax rises in this Budget is still unclear. However, we are sure to learn more about the Chancellor’s thinking for tax in the post-COVID-19 and post-Brexit world. The webcast will cover key developments which could well include:
- Whether, and in what form, future COVID-19 support might be provided for businesses and individuals
- Updates on corporation tax rates and progress at an international level on attributing profits to specific locations
- Incentives for businesses to encourage investment, especially in priority areas
- The redesign of capital gains tax rates and reliefs as well as inheritance tax, both to raise tax revenue and to improve the operation of the taxes
- The use of environmental taxes and incentives, and the role they might play in the Government’s green agenda
EY hopes you are able to join them for what will be an insightful and interactive webcast. Please click here to register.
If you miss or can’t make the live broadcast, the webcast will be available to access on-demand using the same registration link.
Please also see EY's UK Budget webpage for the latest updates and their predictions on what might be included in the budget.
Business Development (led by Deborah O’Neil of NovaBiotics)
enables members to tap into the expertise of other, often larger, member companies, and to develop collaborative solutions to issues facing the sector as a whole.
Finance (led by Hugh Griffith of Nucana BioMed and Alida Capital)
has focussed on the availability of venture capital funding, but also looks at the provision of public sector support for our member companies. Also coordinates the Innovation Tutorial Programme.
HR (led by Fiona Beattie of IQVIA)
is valued by our members as a forum where HR and recruitment issues can be discussed in a collaborative space and pragmatic solutions developed with the secondary and tertiary education sectors.
Diagnostics and MedTech (led by Colin King of Omega Diagnostics Group PLC)
tackles issues of particular relevance to diagnostics companies as they arise, and has also produced a summary of the opportunities for and barriers to growth in the diagnostics sub-sector of life sciences.
Innovation (led by David Pritchard, Axis-Shield, and Douglas Drysdale, HGF)
covers a variety of issues including ownership and commercialisation of University IP through to tax incentives for innovation.
Regulatory and Quality (led by Andrew Waddell of TMQA)
is a forum for SLA members to learn about the regulatory and compliance issues affecting product development and commercialisation, and make representations to regulators and Government as needed. Currently, SLA representatives sit on three MHRA panels.
Digital Health (led by Campbell Grant of Sitekit Solutions)
enables collaboration between member companies in this expanding area, covering personal health software development, telehealthcare systems implementation, health data mining, and life sciences risk analysis systems; and works to help grow companies in this part of the life sciences sector
Cell Therapy (led by Jim Reid of Sistemic)
aims to be a strong industry voice for the stem cell community in Scotland; and makes investors and Government aware of the timeline and costs associated with developing an industry in the sector.
Medicines (led by Tom Stratford of ProStrakan)
works closely with the Scottish Government as it sets up a new partnership between medicine development companies in Scotland and the NHS
Directors Forum (led by Alan Walker of Ryboquin)
provides a space for both Executive and Non-Executive Directors of member companies to meet and exchange views on the sector in Scotland, and to be briefed on hot topics.
Manufacturing (led by John Scott of JnJ)
aims to highlight opportunities for investment in, and benefits of automation, along with pitfalls, challenges and best practice.
Precision Medicine (led by David Bunton of Reprocell)
is focused on getting the most from the recent government investment in the Stratified Medicines Innovation Centre. It aims to bring together SMS-IC with Scottish life sciences companies, and to facilitate cross-company collaborations.
Japan SIG (led by Ken Sutherland of Canon Medical Research Europe Ltd)
is focused on developing the relationship between member companies and Japan, particularly Japanese owned companies based in Scotland.
